XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Statements of Operations and Comprehensive Loss    
Revenue from collaboration and license agreements.   $ 10,000
Costs and expenses:    
Research and development expense $ 14,259,756 20,071,656
General and administrative expense 18,249,318 $ 19,213,637
Restructuring and asset impairment charges $ 7,530,304  
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Restructuring and asset impairment charges Restructuring and asset impairment charges
Total costs and expenses $ 40,039,378 $ 39,285,293
Loss from operations (40,039,378) (39,275,293)
Gain on sale of asset 1,224,945  
Interest income 935,275 2,375,873
Total other income 2,160,220 2,375,873
Net loss and comprehensive loss $ (37,879,158) $ (36,899,420)
Basic net loss per common share (in dollars per share) $ (0.59) $ (0.58)
Diluted net loss per common share (in dollars per share) $ (0.59) $ (0.58)
Basic weighted-average number of common shares outstanding (in shares) 64,477,249 63,342,465
Diluted weighted-average number of common shares outstanding (in shares) 64,477,249 63,342,465